Apigenin attenuates melanoma cell migration by inducing anoikis through integrin and focal adhesion kinase inhibition

Molecules

Volumn 20, Issue 12, 2015, Pages 21157-21166

  Hasnat, Md Abul ^a   Pervin, Mehnaz ^a   Lim, Ji Hong ^a   Lim, Beong Ou ^a  

^a Konkuk University   (South Korea)

Author keywords

Anoikis; Apigenin; Integrin FAK signaling; Melanoma; Migration

Indexed keywords

APIGENIN; FOCAL ADHESION KINASE; INTEGRIN; MESSENGER RNA;

ANOIKIS; ANTAGONISTS AND INHIBITORS; APOPTOSIS; CELL MOTION; CELL PROLIFERATION; DRUG EFFECTS; GENETICS; HUMAN; MELANOMA; METABOLISM; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL CULTURE; WESTERN BLOTTING;

ANOIKIS; APIGENIN; APOPTOSIS; BLOTTING, WESTERN; CELL MOVEMENT; CELL PROLIFERATION; FOCAL ADHESION PROTEIN-TYROSINE KINASES; HUMANS; INTEGRINS; MELANOMA; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 84954357139     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules201219752     Document Type: Article

References (51)

1. Garbe, C.; Peris, K.; Hauschild, A.; Saiag, P.; Middleton, M.; Spatz, A.; Grob, J.J.; Malvehy, J.; Newton-Bishop, J.; Stratigos, A.; et al. Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline-Update 2012. Eur. J. Cancer 2012, 48, 2375-2390.[PubMed]
2. Bogenrieder, T.; Herlyn, M. The molecular pathology of cutaneous melanoma. Cancer Biomark. 2010, 9, 267-286.[PubMed]
3. Fornaro, M.; Manes, T.; Languino, L.R. Integrins and prostate cancer metastases. Cancer Metastasis Rev. 2001, 20, 321-331. [CrossRef][PubMed]
4. Taddei, M.L.; Giannoni, E.; Fiaschi, T.; Chiarugi, P. Anoikis: An emerging hallmark in health and diseases. J. Pathol. 2012, 226, 380-393. [CrossRef][PubMed]
5. Dedhar, S. Integrins and signal transduction. Curr. Opin. Hematol. 1999, 6, 37-43. [CrossRef][PubMed]
6. Giancotti, F.G.; Ruoslahti, E. Integrin signaling. Science 1999, 285, 1028-1032. [CrossRef][PubMed]
7. Juliano, R.L. Signal transduction by cell adhesion receptors and the cytoskeleton: Functions of integrins, cadherins, selectins, and immunoglobulin-superfamily members. Annu. Rev. Pharmacol. Toxicol. 2002, 42, 283-323. [CrossRef][PubMed]
8. Johnson, J.P. Cell adhesion molecules in the development and progression of malignant melanoma. Cancer Metastasis Rev. 1999, 18, 345-357. [CrossRef][PubMed]
9. Clark, E.A.; Brugge, J.S. Integrins and signal transduction pathways: The road taken. Science 1995, 268, 233-239. [CrossRef][PubMed]
10. Schwartz, M.A.; Schaller, M.D.; Ginsberg, M.H. Integrins: Emerging paradigms of signal transduction. Annu. Rev. Cell Dev. Biol. 1995, 11, 549-599. [CrossRef][PubMed]
11. Weiner, T.M.; Liu, E.T.; Craven, R.J.; Cance, W.G. Expression of focal adhesion kinase gene and invasive cancer. Lancet 1993, 342, 1024-1025. [CrossRef]
12. Shin, J.H.; Choi, G.S.; Kang, W.H.; Myung, K.B. Sphingosine 1-phosphate triggers apoptotic signal for B16 melanoma cells via ERK and caspase activation. J. Korean Med. Sci. 2007, 22, 298-304. [CrossRef][PubMed]
13. Kim, H.S.; Kim, M.J.; Kim, E.J.; Yang, Y.; Lee, M.S.; Lim, J.S. Berberine-induced AMPK activation inhibits the metastatic potential of melanoma cells via reduction of ERK activity and COX-2 protein expression. Biochem. Pharmacol. 2012, 83, 385-394. [CrossRef][PubMed]
14. Cheng, A.C.; Lee, M.F.; Tsai, M.L.; Lai, C.S.; Lee, J.H.; Ho, C.T.; Pan, M.H. Rosmanol potently induces apoptosis through both the mitochondrial apoptotic pathway and death receptor pathway in human colon adenocarcinoma COLO 205 cells. Food Chem. Toxicol. 2011, 49, 485-493. [CrossRef][PubMed]
15. Kamida, A.; Fujita, Y.; Kato, I.; Iwai, S.; Ono, K.; Suzuki, M.; Sakurai, Y.; Yura, Y. Effect of neutron capture therapy on the cell cycle of human squamous cell carcinoma cells. Int. J. Radiat. Biol. 2008, 84, 191-199. [CrossRef][PubMed]
16. Budhraja, A.; Gao, N.; Zhang, Z.; Son, Y.O.; Cheng, S.; Wang, X.; Ding, S.; Hitron, A.; Chen, G.; Luo, J.; et al. Apigenin induces apoptosis in human leukemiacells and exhibits anti-leukemic activity in vivo. Mol. Cancer Ther. 2012, 11, 132-142. [CrossRef][PubMed]
17. Byun, S.; Park, J.; Lee, E.; Lim, S.; Yu, J.G.; Lee, S.J.; Chen, H.; Dong, Z.; Lee, K.W.; Lee, H.J. Src kinase is a direct target of apigenin against UVB-induced skininflammation. Carcinogenesis 2013, 34, 397-405. [CrossRef][PubMed]
18. Bektic, J.; Guggenberger, R.; Spengler, B.; Christoffel, V.; Pelzer, A.; Berger, A.P.; Ramoner, R.; Bartsch, G.; Klocker, H. The flavonoid apigenin inhibits the proliferation of prostatic stromal cells via the MAPK-pathway and cell-cycle arrest in G1/S. Maturitas 2006, 55, 37-46. [CrossRef]
19. Lindenmeyer, F.; Li, H.; Menashi, S.; Soria, C.; Lu, H. Apigenin acts on the tumor cell invasion process and regulates protease production. Nutr. Cancer 2001, 39, 139-147. [CrossRef][PubMed]
20. Liu, L.Z.; Fang, J.; Zhou, Q.; Hu, X.; Shi, X.; Jiang, B.H. Apigenin inhibits expression of vascular endothelial growth factor and angiogenesis in human lung cancer cells: Implication of chemoprevention of lung cancer. Mol. Pharmacol. 2005, 68, 635-643.[PubMed]
21. Fang, J.; Xia, C.; Cao, Z.; Zheng, J.Z.; Reed, E.; Jiang, B.H. Apigenin inhibits VEGF and HIF-1 expression via PI3K/AKT/p70S6K1 and HDM2/p53 pathways. FASEB J. 2005, 19, 342-353. [CrossRef][PubMed]
22. Trochon, V.; Blot, E.; Cymbalista, F. Apigenin inhibits endothelial-cell proliferation in G(2)/M phase whereas it stimulates smooth-muscle cells by inhibiting P21 and P27 expression. Int. J. Cancer 2000, 85, 691-696. [CrossRef]
23. Schindler, R.; Mentlein, R. Flavonoids and vitamin E reduce the release of the angiogenic peptide vascular endothelial growth factor from human tumor cells. J. Nutr. 2006, 136, 1477-1482.[PubMed]
24. Das, S.; Das, J.; Samadder, A.; Paul, A.; Khuda-Bukhsh, A.R. Efficacy of PLGA-loaded apigenin nanoparticles in Benzo[a]pyrene and ultraviolet-B induced skin cancer of mice: Mitochondria mediated apoptotic signalling cascades. Food Chem. Toxicol. 2013, 62, 670-680. [CrossRef][PubMed]
25. Huang, Y.T.; Kuo, M.L.; Liu, J.Y.; Huang, S.Y.; Lin, J.K. Inhibitions of protein kinase C and proto-oncogene expressions in NIH 3T3 cells by apigenin. Eur. J. Cancer 1996, 32, 146-151. [CrossRef]
26. Agullo, G.; Gamet-Payrastre, L.; Manenti, S.; Viala, C.; Remesy, C.; Chap, H.; Payrastre, B. Relationship between flavonoid structure and inhibition of phosphatidylinositol 3-kinase: A comparison with tyrosine kinase and protein kinase C inhibition. Biochem. Pharmacol. 1997, 53, 1649-1657. [CrossRef]
27. Yin, F.; Giuliano, A.E.; Law, R.E.; van Herle, A.J. Apigenin inhibits growth and induces G2/M arrest by modulating cyclin-CDK regulators and ERK MAP kinase activation in breast carcinoma cells. Anticancer Res. 2001, 21, 413-420.[PubMed]
28. Llorens, F.; Miro, F.A.; Casanas, A.; Roher, N.; Garcia, L.; Plana, M.; Gomez, N.; Itarte, E. Unbalanced activation of ERK1/2 and MEK1/2 in apigenin-induced HeLa cell death. Exp. Cell Res. 2004, 299, 15-26. [CrossRef][PubMed]
29. Shukla, S.; Gupta, S. Apigenin-induced cell cycle arrest is mediated by modulation of MAPK, PI3K-Akt, and loss of cyclin D1 associated retinoblastoma dephosphorylation in human prostate cancer cells. Cell Cycle 2007, 6, 1102-1114. [CrossRef][PubMed]
30. Albelda, S.M.; Mette, S.A.; Elder, D.E.; Stewart, R.; Damjanovich, L.; Herlyn, M.; Buck, C.A. Integrin distribution in malignant melanoma: Association of the beta 3 subunit with tumor progression. Cancer Res. 1990, 50, 6757-6764.[PubMed]
31. Van Belle, P.A.; Elenitsas, R.; Satyamoorthy, K.; Wolfe, J.T.; Guerry, D.T.; Schuchter, L.; van Belle, T.J.; Albelda, S.; Tahin, P.; Herlyn, M.; et al. Progression-related expression of beta3 integrin in melanomas and nevi. Hum Pathol. 1999, 30, 562-567. [CrossRef]
32. Oltvai, Z.; Milliman, C.; Korsmeyer, S.J. Bcl-2 heterodimerizes in vivo with a conversed homolog, Bax, that accelerates programmed cell death. Cell 1993, 74, 609-619. [CrossRef]
33. Germain, M.; Affar, E.B.; D'Amours, D.; Dixit, V.M.; Salvesen, G.S.; Poirier, G.G. Cleavage of automodified poly(ADP-ribose) polymerase during apoptosis. J. Biol. Chem. 1999, 274, 28379-28384. [CrossRef][PubMed]
34. Yan, N.; Shi, Y. Mechanisms of apoptosis through structural biology. Annu. Rev. Cell Dev. Biol. 2005, 21, 35-56. [CrossRef][PubMed]
35. Fofaria, N.M.; Kim, S.H.; Srivastava, S.K. Piperine Causes G1 Phase Cell Cycle Arrest and Apoptosis in Melanoma Cells through Checkpoint Kinase-1 Activation. PLoS ONE 2014, 9, e94298. [CrossRef][PubMed]
36. Eggermont, A.; Robert, C. Melanoma in 2011: A new paradigm tumor for drug development. Nat. Rev. Clin. Oncol. 2012, 10, 74-76. [CrossRef][PubMed]
37. Sharma, S.; Kelly, T.; Jones, P. Epigenetics in cancer. Carcinogenesis 2009, 31, 27-36. [CrossRef][PubMed]
38. Patel, D.; Shukla, S.; Gupta, S. Apigenin and cancer chemoprevention: Progress, potential and promise (review). Int. J. Oncol. 2007, 30, 233-245. [CrossRef][PubMed]
39. Guo, W.; Giancotti, F.G. Integrin signalling during tumour progression. Nat. Rev. Mol. Cell Biol. 2004, 5, 816-826. [CrossRef][PubMed]
40. Pignatelli, M.; Cardillo, M.R.; Hanby, A.M.; Stamp, G.W.H. Integrins and their accessory adhesion molecules in mammary carcinomas: Loss of polarization in poorly differentiated tumors. Hum. Pathol. 1992, 23, 1159-1166. [CrossRef]
41. Schaller, M.D.; Parsons, J.T. Focal adhesion kinase and associated proteins. Curr. Opin. Cell Biol. 1994, 6, 705-710. [CrossRef]
42. Hecker, T.P.; Gladson, C.L. Focal adhesion kinase in cancer. Front. Biosci. 2003, 8, 705-714. [CrossRef]
43. Hunger-Glaser, I.; Salazar, E.P.; Sinnett-Smith, J.; Rozengurt, E. Bombesin, lysophosphatidic acid, and epidermal growth factor rapidly stimulate focal adhesion kinase phosphorylation at Ser-910: Requirement for ERK activation. J. Biol. Chem. 2003, 278, 22631-22643. [CrossRef][PubMed]
44. Sieg, D.J.; Hauck, C.R.; Ilic, D.; Klingbeil, C.K.; Schaefer, E.; Damsky, C.H.; Schlaepfer, D.D. FAK integrates growth-factor and integrin signals to promote cell migration. Nat. Cell Biol. 2000, 2, 249-256.[PubMed]
45. Johnson, G.L.; Lapadat, R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 2002, 298, 1911-1920. [CrossRef][PubMed]
46. Frisch, S.M.; Frances, H. Disruption of epithelial cell-matrix interactions induce apoptosis. J. Cell Biol. 1994, 124, 619-626. [CrossRef][PubMed]
47. Wolf, B.B.; Green, D.R. Suicidal tendencies: Apoptotic cell death by caspase family proteinases. J. Biol. Chem. 1999, 274, 20049-20052. [CrossRef][PubMed]
48. Wick, A.; Wick, W.; Hirrlinger, J.; Gerhardt, E.; Dringen, R.; Dichgans, J.; Weller, M.; Schulz, J.B. Chemotherapy-induced cell death in primary cerebellar granule neurons but not in astrocytes: In vitro paradigm of differential neurotoxicity. J. Neurochem. 2004, 91, 1067-1074. [CrossRef][PubMed]
49. Inayat-Hussain, S.H.; Osman, A.B.; Din, L.B.; Ali, A.M.; Snowden, R.T.; MacFarlane, M.; Cain, K. Caspases-3 and -7 are activated in goniothalamin-induced apoptosis in human Jurkat T-cells. FEBS Lett. 1999, 456, 379-383. [CrossRef]
50. Sauter, E.R.; Yeo, U.C.; von Stemm, A.; Zhu, W.; Litwin, S.; Tichansky, D.S.; Pistritto, G.; Nesbit, M.; Pinkel, D.; Herlyn, M.; et al. Cyclin D1 is a candidate oncogene in cutaneous melanoma. Cancer Res. 2002, 62, 3200-3206.[PubMed]
51. Ahmad, I.; Jimenez, H.; Yaacob, N.S.; Yusuf, N. Tualang honey protects keratinocytes from ultraviolet radiation-induced inflammation and DNA damage. Photochem. Photobiol. 2012, 88, 1198-1204. [CrossRef][PubMed]